CA98980M1095 - Common Stock
ZOMEDICA CORP
NYSEARCA:ZOM (3/28/2024, 8:00:00 PM)
After market: 0.1461 +0 (+0.14%)0.1459
+0 (+1.32%)
Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company is headquartered in Ann Arbor, Michigan and currently employs 85 full-time employees. The company went IPO on 2013-10-28. The firm is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The firm's Diagnostics segment consists of TRUFORMA products. Its Therapeutics segment consists of PulseVet and Assisi products. Its TRUFORMA Bulk Acoustic Wave (BAW) point-of-care diagnostic platform is marketed with full diagnostic and thyroid panels for dogs and cats that include the only assays of these types available at the point of care to test for feline optimized TSH, endogenous ACTH, Free T4, and quantitative cortisol, along with a total T4 assay. The VetGuardian is its zero-touch vital signs remote monitoring system that enables contact-free, continuous monitoring of a pet's vital signs. The PulseVet is its electrohydraulic shockwave therapy platform. Its Assisi Loop line of products treats pain and inflammation through the delivery of targeted pulsed electromagnetic field focused energy (tPEMF).
ZOMEDICA CORP
100 Phoenix Drive, Suite 125
Ann Arbor MICHIGAN 48108
P: 17343692555
CEO: Robert Cohen
Employees: 85
Website: https://zomedica.com/
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions.
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks.
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future.
Zomedica expects strong revenue growth in 2023, with Q4 revenue projected to be over $7 million and total 2023 revenue expected to exceed $25 million.
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors.
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs.
Here you can normally see the latest stock twits on ZOM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: